Stable Nebulization and Muco-Trapping Properties of Regdanvimab/in-006 Support Its Development As a Potent, Dose-Saving Inhaled Therapy for COVID-19
Bioengineering & Translational Medicine(2022)
Key words
antiviral,COVID-19,drug delivery,inhaled delivery,mAb,nebulization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined